drugset / Trial / NCT04150146

To Evaluate Food Effect on the Pharmacokinetics of Rebamipide in Healthy Volunteers

NCT04150146

Phase 1 Completed 24 enrolled Korea Otsuka Pharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelOther

Summary

This is a randomized, open label, single dose, crossover study to evaluate the food effect on the pharmacokinetics after single oral dose of "rebamipide SR 150 mg" in healthy adult volunteers.

Timeline

Start
2019-07-05
Primary completion
2019-07-14
Completion
2019-07-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Rebamipide Small molecule 150 mg Oral

Indications

No indication recorded.